NYU Cancer Institute Researcher Among First NIH Eureka Grant Recipients for Exceptionally Innovative Research
Wednesday, September 3, 2008 - 14:28
in Mathematics & Economics
The National Institutes of Health (NIH) has awarded $42.2 million to fund 38 exceptionally innovative research projects that could have an extraordinarily significant impact on many areas of science. Michelle Krogsgaard, Ph.D, assistant professor of pathology at the NYU Cancer Institute, is the first NYU School of Medicine recipient of the EUREKA award.